Whartons Jelly Derived Mesenchymal Stem Cells

Wharton s jelly derived mesenchymal stem cells wj mscs have been introduced as a possible therapy in hypoxic ischemic encephalopathy hie.

Whartons jelly derived mesenchymal stem cells.

Wharton s jelly mesenchymal stromal stem cells are harvested from umbilical cord tissue and are considered by many regenerative experts to have the most potential for effective cell based therapy with the added benefit of being far easier and less invasive to retrieve. Thus more research is needed on the isolation and characterization of mesenchymal ste. We report a 16 year old boy who was treated with wj mscs in the course of hie due to post cardiopulmonary resuscitation. According to the authors of the review these stem cells can be collected during millions of births each year at the time of delivery.

In a recent study wharton s jelly tissue transplantation has shown to be able to reduce traumatic brain injury and may have therapeutic potential. Wharton s jelly is therefore a potential source of adult stem cells often collected from cord blood. Evidences that these cells possess therapeutic properties are constantly accumulating. Wharton s jelly derived mesenchymal stem cells wj mscs have a high proliferation valency and they do not produce teratogen or carcinogen after subsequent transplantation.

Wharton s jelly derived mesenchymal stem cells may have immunomodulatory effect on lymphocytes. They are known as regenerative medicine.